Search research articles
Contact Us
Filters
Showing results (51-60 of 83) with videos related to
Page
of 9
Sort By:
BJU International
|
October 17, 2021
Molecular margin status after radical prostatectomy using glutathione S-transferase P1 (GSTP1) promoter hypermethylation
Jörn H Witt, Maria Friedrich, Burkhard Jandrig, et al.
Der Urologe. Ausg. A
|
October 23, 2012
[Placement of percutaneous nephrostomy by open magnetic resonance imaging: clinical results and current status in urology]
M Porsch, J J Wendler, F Fischbach, et al.
Der Urologe. Ausg. A
|
November 20, 2012
[Magnetic resonance urography in pediatric urology]
D Schindele, C Furth, U B Liehr, et al.
Nature Methods
|
April 4, 2017
Temporally precise labeling and control of neuromodulatory circuits in the mammalian brain
Dongmin Lee, Meaghan Creed, Kanghoon Jung, et al.
Contemporary Clinical Trials
|
May 13, 2015
A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial)
J J Wendler, M Porsch, S Nitschke, et al.
Aktuelle Urologie
|
August 10, 2012
[HIFU in salvage treatment of patients with prostate cancer after primary external radiation therapy--status 2012]
D Baumunk, H Cash, J Ebbing, et al.
Polish Journal of Radiology
|
March 12, 2016
Irreversible Electroporation (IRE): Standardization of Terminology and Reporting Criteria for Analysis and Comparison
Johann J Wendler, Katharina Fischbach, Jens Ricke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 27, 2019
Prospective evaluation of CT-guided HDR brachytherapy as a local ablative treatment for renal masses: a single-arm pilot trial
R Damm, T Streitparth, P Hass, et al.
Cancer Research
|
December 1, 1995
67Ga citrate versus 99mTc-labeled LL2-Fab' (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma
W S Becker, T M Behr, F Cumme, et al.
Der Urologe. Ausg. A
|
November 10, 2012
[Irreversible electroporation: the new generation of local ablation techniques for renal cell carcinoma]
U-B Liehr, J J Wendler, S Blaschke, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 83) with videos related to
Sort By:
Page
of 9
BJU International
|
October 17, 2021
Molecular margin status after radical prostatectomy using glutathione S-transferase P1 (GSTP1) promoter hypermethylation
Jörn H Witt, Maria Friedrich, Burkhard Jandrig, et al.
Der Urologe. Ausg. A
|
October 23, 2012
[Placement of percutaneous nephrostomy by open magnetic resonance imaging: clinical results and current status in urology]
M Porsch, J J Wendler, F Fischbach, et al.
Der Urologe. Ausg. A
|
November 20, 2012
[Magnetic resonance urography in pediatric urology]
D Schindele, C Furth, U B Liehr, et al.
Nature Methods
|
April 4, 2017
Temporally precise labeling and control of neuromodulatory circuits in the mammalian brain
Dongmin Lee, Meaghan Creed, Kanghoon Jung, et al.
Contemporary Clinical Trials
|
May 13, 2015
A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial)
J J Wendler, M Porsch, S Nitschke, et al.
Aktuelle Urologie
|
August 10, 2012
[HIFU in salvage treatment of patients with prostate cancer after primary external radiation therapy--status 2012]
D Baumunk, H Cash, J Ebbing, et al.
Polish Journal of Radiology
|
March 12, 2016
Irreversible Electroporation (IRE): Standardization of Terminology and Reporting Criteria for Analysis and Comparison
Johann J Wendler, Katharina Fischbach, Jens Ricke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
July 27, 2019
Prospective evaluation of CT-guided HDR brachytherapy as a local ablative treatment for renal masses: a single-arm pilot trial
R Damm, T Streitparth, P Hass, et al.
Cancer Research
|
December 1, 1995
67Ga citrate versus 99mTc-labeled LL2-Fab' (anti-CD22) fragments in the staging of B-cell non-Hodgkin's lymphoma
W S Becker, T M Behr, F Cumme, et al.
Der Urologe. Ausg. A
|
November 10, 2012
[Irreversible electroporation: the new generation of local ablation techniques for renal cell carcinoma]
U-B Liehr, J J Wendler, S Blaschke, et al.
Page
of 9